SION Sionna Therapeutics, Inc.

NASDAQ
$5.23

Sionna Therapeutics, Inc. (SION) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.62 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -88.9% since its last earnings release on August 6, 2026.

Sionna Therapeutics Missed Consensus Estimates
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.62)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.17

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Sionna Therapeutics, Inc.

Sionna Therapeutics Inc. is a clinical-stage biopharmaceutical company by developing novel medicines that normalize the function of the CFTR protein. Sionna Therapeutics Inc. is based in BOSTON.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.